Multicenter cohort association study of SLC2A1 single nucleotide polymorphisms and age-related macular degeneration

Purpose Age-related macular degeneration (AMD) is a major cause of blindness in older adults and has a genetically complex background. This study examines the potential association between single nucleotide polymorphisms (SNPs) in the glucose transporter 1 (SLC2A1) gene and AMD. SLC2A1 regulates the bioavailability of glucose in the retinal pigment epithelium (RPE), which might influence oxidative stress–mediated AMD pathology. Methods Twenty-two SNPs spanning the SLC2A1 gene were genotyped in 375 cases and 199 controls from an initial discovery cohort (the Amsterdam-Rotterdam-Netherlands study). Replication testing was performed in The Rotterdam Study (the Netherlands) and study populations from Würzburg (Germany), the Age Related Eye Disease Study (AREDS; United States), Columbia University (United States), and Iowa University (United States). Subsequently, a meta-analysis of SNP association was performed. Results In the discovery cohort, significant genotypic association between three SNPs (rs3754219, rs4660687, and rs841853) and AMD was found. Replication in five large independent (Caucasian) cohorts (4,860 cases and 4,004 controls) did not yield consistent association results. The genotype frequencies for these SNPs were significantly different for the controls and/or cases among the six individual populations. Meta-analysis revealed significant heterogeneity of effect between the studies. Conclusions No overall association between SLC2A1 SNPs and AMD was demonstrated. Since the genotype frequencies for the three SLC2A1 SNPs were significantly different for the controls and/or cases between the six cohorts, this study corroborates previous evidence that population dependent genetic risk heterogeneity in AMD exists.

[1]  O. Franco,et al.  The Rotterdam Study: 2012 objectives and design update , 2011, European Journal of Epidemiology.

[2]  R. Fernandes,et al.  Reactive oxygen species downregulate glucose transport system in retinal endothelial cells. , 2011, American journal of physiology. Cell physiology.

[3]  A. Lotery,et al.  Oxidation and age-related macular degeneration: insights from molecular biology , 2010, Expert Reviews in Molecular Medicine.

[4]  R. T. Smith,et al.  The complement component 5 gene and age-related macular degeneration. , 2010, Ophthalmology.

[5]  D. Baas,et al.  The dynamic nature of Bruch's membrane , 2010, Progress in Retinal and Eye Research.

[6]  P. Mitchell,et al.  Toll-like receptor polymorphisms and age-related macular degeneration: replication in three case-control samples. , 2009, Investigative ophthalmology & visual science.

[7]  C. Hanis,et al.  Assessment of 193 candidate genes for retinopathy in African Americans with type 1 diabetes. , 2009, Archives of ophthalmology.

[8]  B. Gold,et al.  Multilocus analysis of age-related macular degeneration , 2009, European Journal of Human Genetics.

[9]  Ammarin Thakkinstian,et al.  How to use an article about genetic association: B: Are the results of the study valid? , 2009, JAMA.

[10]  C. Klaver,et al.  The SERPING1 gene and age-related macular degeneration , 2008, The Lancet.

[11]  S. Ennis,et al.  Association between the SERPING1 gene and age-related macular degeneration: a two-stage case–control study , 2008, The Lancet.

[12]  G. Parmigiani,et al.  Toll-like receptor 3 and geographic atrophy in age-related macular degeneration. , 2008, The New England journal of medicine.

[13]  C. Granier,et al.  Risk genotypes and haplotypes of the GLUT1 gene for type 2 diabetic nephropathy in the Tunisian population , 2008, Annals of human biology.

[14]  E. Kuipers,et al.  The Rotterdam Study: 2010 objectives and design update , 2007, European Journal of Epidemiology.

[15]  Evangelos Evangelou,et al.  Heterogeneity in Meta-Analyses of Genome-Wide Association Investigations , 2007, PloS one.

[16]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[17]  I. Deary,et al.  Complement C3 variant and the risk of age-related macular degeneration. , 2007, The New England journal of medicine.

[18]  Eden R Martin,et al.  No gene is an island: the flip-flop phenomenon. , 2007, American journal of human genetics.

[19]  N. Camp,et al.  A Variant of the HTRA1 Gene Increases Susceptibility to Age-Related Macular Degeneration , 2006, Science.

[20]  C. Szabó,et al.  Early diabetes-induced biochemical changes in the retina: comparison of rat and mouse models , 2006, Diabetologia.

[21]  R. T. Smith,et al.  Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration , 2006, Nature Genetics.

[22]  A. Hofman,et al.  Dietary intake of antioxidants and risk of age-related macular degeneration. , 2005, JAMA.

[23]  A. Demaine,et al.  Glucose transporter polymorphisms are associated with clear-cell renal carcinoma. , 2005, Cancer genetics and cytogenetics.

[24]  P. Brown,et al.  Differential gene expression in anatomical compartments of the human eye , 2005, Genome Biology.

[25]  J. Ioannidis,et al.  Why Most Published Research Findings Are False , 2005, PLoS medicine.

[26]  Olaf Strauss,et al.  The retinal pigment epithelium in visual function. , 2005, Physiological reviews.

[27]  R. T. Smith,et al.  A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Ott,et al.  Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.

[29]  A. Demaine,et al.  A novel polymorphism in the 5' flanking region of the glucose transporter (GLUT1) gene is strongly associated with diabetic nephropathy in patients with Type 1 diabetes mellitus. , 2005, Journal of diabetes and its complications.

[30]  Johanna M Seddon,et al.  The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. , 2005, Archives of ophthalmology.

[31]  Elias Zintzaras,et al.  Association between the GLUT1 gene polymorphism and the risk of diabetic nephropathy: a meta-analysis , 2005, Journal of Human Genetics.

[32]  M. Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[33]  M. Zarbin.  Current concepts in the pathogenesis of age-related macular degeneration. , 2004, Archives of ophthalmology.

[34]  R. Klein,et al.  Causes and prevalence of visual impairment among adults in the United States. , 2004, Archives of ophthalmology.

[35]  Benita J. O’Colmain,et al.  Prevalence of age-related macular degeneration in the United States. , 2004, Archives of ophthalmology.

[36]  G. M. Liuzzi,et al.  Inhibition of AQP4 expression in astrocytes by RNAi determines alterations in cell morphology, growth, and water transport and induces changes in ischemia related genes , 2003 .

[37]  E. Lander,et al.  Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease , 2003, Nature Genetics.

[38]  D. Moczulski,et al.  Minor effect of GLUT1 polymorphisms on susceptibility to diabetic nephropathy in type 1 diabetes. , 2002, Diabetes.

[39]  J. Hirschhorn,et al.  A comprehensive review of genetic association studies , 2002, Genetics in Medicine.

[40]  M. Stevens,et al.  Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats , 2001, Diabetologia.

[41]  A. Demaine,et al.  Polymorphisms of the glucose transporter (GLUT1) gene are associated with diabetic nephropathy. , 2001, Kidney international.

[42]  D. Moczulski,et al.  Role of GLUT1 gene in susceptibility to diabetic nephropathy in type 2 diabetes. , 2001, Kidney international.

[43]  M. Boulton,et al.  The role of oxidative stress in the pathogenesis of age-related macular degeneration. , 2000, Survey of ophthalmology.

[44]  D. Janigro.  Blood–brain barrier, ion homeostasis and epilepsy: possible implications towards the understanding of ketogenic diet mechanisms , 1999, Epilepsy Research.

[45]  Zhihong Liu,et al.  Glucose transporter (GLUT1) allele (XbaI-) associated with nephropathy in non-insulin-dependent diabetes mellitus. , 1999, Kidney international.

[46]  L. Aiello,et al.  Hypoxia upregulates glucose transport activity through an adenosine-mediated increase of GLUT1 expression in retinal capillary endothelial cells. , 1998, Diabetes.

[47]  C. Llor,et al.  GLUT1 gene polymorphism in non-insulin-dependent diabetes mellitus: genetic susceptibility relationship with cardiovascular risk factors and microangiopathic complications in a Mediterranean population. , 1998, Diabetes research and clinical practice.

[48]  V. Mohan,et al.  Genetic contribution of polymorphism of the GLUT1 and GLUT4 genes to the susceptibility to type 2 (non-insulin-dependent) diabetes mellitus in different populations , 1996, Acta Diabetologica.

[49]  A. Matsutani,et al.  HepG2/erythrocyte glucose transporter (GLUT1) gene in NIDDM: a population association study and molecular scanning in Japanese subjects , 1995, Diabetologia.

[50]  P T de Jong,et al.  An international classification and grading system for age-related maculopathy and age-related macular degeneration , 1995 .

[51]  Johannes R. Vingerling,et al.  The prevalence of age-related maculopathy in the Rotterdam Study. , 1995, Ophthalmology.

[52]  B. Glasgow,et al.  GLUT1 glucose transporter expression in the diabetic and nondiabetic human eye. , 1994, Investigative ophthalmology & visual science.

[53]  G. Hageman,et al.  Characterization of glucose transporter isoforms in the adult and developing human eye. , 1993, Endocrinology.

[54]  D. Newsome,et al.  Glucose uptake, hexose monophosphate shunt activity, and oxygen consumption in cultured human retinal pigment epithelial cells. , 1990, Investigative ophthalmology & visual science.

[55]  R N Kalaria,et al.  Reduced Glucose Transporter at the Blood‐Brain Barrier and in Cerebral Cortex in Alzheimer Disease , 1989, Journal of neurochemistry.

[56]  E. Kremmer,et al.  ARMS2 is a constituent of the extracellular matrix providing a link between familial and sporadic age-related macular degenerations. , 2010, Investigative ophthalmology & visual science.

[57]  M. Daly,et al.  Variation near complement factor I is associated with risk of advanced AMD , 2009, European Journal of Human Genetics.

[58]  D. Rao,et al.  Genotyping errors and their impact on genetic analysis. , 2008, Advances in genetics.

[59]  A. Ramé.  [Age-related macular degeneration]. , 2006, Revue de l'infirmiere.

[60]  Lars G Fritsche,et al.  Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. , 2005, Human molecular genetics.

[61]  The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. , 2001, American journal of ophthalmology.

[62]  Dean P. Jones,et al.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. , 2001, Archives of ophthalmology.

[63]  Jennifer I. Lim,et al.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.

[64]  C. Klaver,et al.  An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. , 1995, Survey of ophthalmology.